Tirzepatide was previously shown to provide sustained weight reductions in adults with obesity. New longer-term findings in adults with both obesity and prediabetes are summarized in a short video.

Eli Lilly's tirzepatide has been shown to significantly ... over the weekend and simultaneously published in the New England Journal of Medicine – also showed that treatment with the dual ...

In this week’s edition of InnovationRx, we look at Eli Lilly’s weight-loss pill stockpiling, scaling stem cell manufacturing, ...

In an article published in The New England Journal of Medicine in 2021, doctors also noted the number of patients reporting alopecia in tirzepatide trials for obesity by Eli Lilly. In a recent ...

Eli Lilly’s diabetes and obesity therapy tirzepatide could find a use as a treatment for obstructive sleep apnoea (OSA) after hitting the mark in a pair of phase 3 trials. OSA is a prevalent ...

according to a study in The New England Journal of Medicine. Congenital generalized lipodystrophy (CGL), which affects only a few thousand people worldwide, results in severe metabolic disease ...

Larger outsourcing facilities, which are FDA-regulated and can create prescription-specific compounded drugs as well as bulk orders, must cease compounding, distributing or dispensing tirzepatide ...

The active ingredient in Mounjaro is tirzepatide. Zepbound also contains tirzepatide and is FDA approved for weight loss and weight management. Tirzepatide works by imitating the effects of ...